At a glance
- Originator Bioglan Pharma [CEASED]
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 31 Dec 2002 Discontinued - Phase-II for Pain in United Kingdom (Intranasal)
- 12 Oct 2001 Phase-II clinical trials for Pain in United Kingdom (Intranasal)